Home » Newsletters » BioWorld Science

BioWorld Science

March 28, 2022

View Archived Issues

Identification of sites of metabolic liability for KRM-II-81 and evaluation of a deuterated analogue

Variant in the CTR1 gene causes novel disorder of copper metabolism

MK-6158: sGC stimulator clinical candidate for pulmonary arterial hypertension

Novel nonhallucinogenic DMT analogues as drug candidates for mental health and addiction disorders

Phosphatidylserine is crucial for synaptic pruning in adult-born neurons

New antibacterials identified at Roche

Yale University divulges new oligosaccharyltransferase complex inhibitors

HDAC inhibitors disovered at Chong Kun Dang Pharmaceutical

Dompe Farmaceutici describes new peptides with angiogenic activity

Bayer patents P2X purinoceptor 4 antagonists

Novel USP30 inhibitors as potential anti-Parkinson candidates

Novartis details discovery, preclinical data of novel antimalarial compound INE-963

Sosei Heptares' GLP-1/2 agonist HTL-0030023 shows promising results for treating NAFLD and NASH

Missense variants in DDX39B linked to novel syndrome of global neurodevelopmental delay

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...